Treatment of Small Cell Carcinoma of the Bladder With Chemotherapy and Radiation after Transurethral Resection of a Bladder Tumor

被引:19
作者
Bryant, Curtis M. [1 ]
Dang, Long H. [2 ]
Stechmiller, Bruce K. [2 ]
Gilbert, Scott M. [3 ]
Morris, Christopher G. [3 ]
Zlotecki, Robert A. [3 ]
机构
[1] Univ Florida, Dept Radiat Oncol, 2000 SW Archer Rd,POB 100385, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Med, Div Med Oncol, 2000 SW Archer Rd,POB 100385, Gainesville, FL 32610 USA
[3] Univ Florida, Dept Urol, 2000 SW Archer Rd,POB 100385, Gainesville, FL 32610 USA
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2016年 / 39卷 / 01期
关键词
radiotherapy; chemotherapy; bladder cancer; outcomes; URINARY-BLADDER; OUTCOMES;
D O I
10.1097/COC.0000000000000027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives:Small cell carcinoma of the bladder is a rare, aggressive cancer with a high potential for metastases. We analyzed outcomes of patients with small cell carcinoma of the bladder treated curatively with chemotherapy and radiotherapy with bladder preservation.Materials and Methods:We reviewed the medical records of 11 patients treated with radiotherapy at our institution between 1988 and 2010 for biopsy-proven small cell carcinoma of the bladder clinically localized to the true pelvis. Each patient received transurethral resection of the bladder tumor followed by induction chemotherapy and consolidative radiation or concurrent chemoradiation. After completing radiotherapy, cystoscopy was performed to evaluate local response. Overall survival, distant metastasis-free survival, local-regional control, and complete response rates are reported.Results:The median follow-up was 1.1 years for all patients and 10 years for survivors. Nine patients had clinical T3-T4 disease and 3 had node-positive disease. All patients were treated with conventional radiotherapy (median dose, 59 Gy) and cisplatin-based chemotherapy. Eight patients had a cystoscopy after completing chemoradiation, all of whom had a biopsy-proven complete response. The remaining 3 patients developed a distant metastasis before cystoscopy could be performed. The 3-year overall survival rate was 24%; the distant metastasis-free survival rate was 27%; and the local-regional control rate was 78%. All patients who achieved local control maintained functioning bladders. No Common Terminology Criteria for Adverse Events toxicity scale, version 3.0 late grade 3 genitourinary or gastrointestinal toxicities occurred.Conclusions:Primary chemoradiation provides reasonable local-regional control rates with a functioning bladder, even for patients with locally advanced disease, and is an effective alternative to cystectomy when aiming for bladder conservation.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 50 条
  • [1] Transdifferentiation of Small Cell Carcinoma of the Urinary Bladder from Urothelial Carcinoma after Transurethral Resection of a Bladder Tumor, Intravesical Bacillus Calmette-Guerin Instillation, and Chemotherapy: A Case Report
    Morozumi, Kento
    Namiki, Shunichi
    Kudo, Takashi
    Aizawa, Masataka
    Ioritani, Naomasa
    Sakamoto, Kazuhiro
    Nakamura, Yasuhiro
    CASE REPORTS IN ONCOLOGY, 2016, 9 (03): : 786 - 791
  • [2] Intravesical recurrence after bladder sparing treatment of small cell carcinoma of the bladder: Characteristics, treatment, and outcome
    van de Kamp, Maaike
    Meijer, Richard
    Pos, Floris
    Kerst, Martijn
    van Werkhoven, Eric
    van Rhijn, Bas
    Horenblas, Simon
    Bex, Axel
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (06) : 307.e1 - 307.e8
  • [3] Predicting the Lymphovascular Invasion in Carcinoma Bladder at Transurethral Resection
    Nallabothula, Anil Kumar
    Mudunuri, Harsha Vardhana Varma
    Nalumaru, Anirudh Suseel
    Kodamanchile, Viswanth
    Varanasi, Sai Bhashya Vamsi Krishna
    Yadlapalli, Naveen Kumar
    Earla, Dinesh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [4] Effect of internal iliac artery chemotherapy after transurethral resection of bladder tumor for muscle invasive bladder cancer
    Jianxing Li
    Qi Wang
    Bo Xiao
    Xin Zhang
    Chinese Journal of Cancer Research, 2014, 26 (05) : 558 - 563
  • [5] Effect of internal iliac artery chemotherapy after transurethral resection of bladder tumor for muscle invasive bladder cancer
    Li, Jianxing
    Wang, Qi
    Xiao, Bo
    Zhang, Xin
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (05) : 558 - 563
  • [6] Increase in Circulating Tumor Cells in Invasive Bladder Cancer After Transurethral Resection of Bladder Tumor
    Haga, Nobuhiro
    Tsubouchi, Kazuna
    Maruta, Hiroko
    Koguchi, Tomoyuki
    Hoshi, Seiji
    Ogawa, Soichiro
    Akaihata, Hidenori
    Hata, Junya
    Kojima, Yoshiyuki
    ANTICANCER RESEARCH, 2020, 40 (08) : 4299 - 4307
  • [7] 15-Year Survival Rates after Transurethral Resection and Radiochemotherapy or Radiation in Bladder Cancer Treatment
    Krause, Frens Steffen
    Walter, Bernhard
    Ott, Oliver Josef
    Haeberle, Lothar
    Weiss, Christian
    Roedel, Claus
    Wullich, Bernd
    Sauer, Rolf
    ANTICANCER RESEARCH, 2011, 31 (03) : 985 - 990
  • [8] Radiotherapy concurrent with weekly gemcitabine after transurethral tumor resection in muscle nvasive bladder cancer
    Demirci, Umut
    Dizdar, Omer
    Cetindag, M. Faik
    Altinova, Serkan
    Ozsavran, Atiye
    Dede, Didem Sener
    Kizilirmak, Nurgul
    Eraslan, F. Aysun
    Yalcin, Bulent
    Cinkir, Havva Yesil
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (04) : 704 - 707
  • [9] Approaching the optimal transurethral resection of a bladder tumor
    Jurewicz, Michael
    Soloway, Mark S.
    TURKISH JOURNAL OF UROLOGY, 2014, 40 (02): : 73 - 77
  • [10] Radiation Therapy as Definitive Local Treatment in Patients with Limited-Stage Small Cell Carcinoma of the Bladder: Does total dose matter?
    Germino, Elizabeth
    Fischer-Valuck, Benjamin W.
    Rudra, Soumon
    Rao, Yuan James
    Contreras, Jessika
    Abraham, Christopher
    Michalski, Jeff
    Gay, Hiram
    BLADDER CANCER, 2018, 4 (03) : 311 - 317